Szade, Agata http://orcid.org/0000-0002-0575-4659
Szade, Krzysztof http://orcid.org/0000-0002-7227-4276
Mahdi, Mahdi http://orcid.org/0000-0001-5839-8339
Józkowicz, Alicja http://orcid.org/0000-0002-7317-260X
Funding for this research was provided by:
Ministerstwo Nauki i Szkolnictwa Wyższego (0458/E-338/STYP/13/2018, 0459/E‐338/STYP/13/2018)
Narodowe Centrum Nauki (2019/35/D/NZ3/04406, 2018/30/M/NZ5/00869, 2018/30/A/NZ3/00495)
Fundacja na rzecz Nauki Polskiej (POIR.04.04.00-00-5F16/18-00)
Fundacja DKMS
Narodowe Centrum Badań i Rozwoju (LIDER/37/0133/L-11/19/NCBR/2020)
Jagiellonian University in Krakow
Article History
Received: 13 October 2020
Revised: 9 February 2021
Accepted: 24 February 2021
First Online: 31 March 2021
Declarations
:
: AS, KS and AJ are the coinventors of the patents US10010557 and US10328085: Cobalt porphyrins for the treatment of blood-related disorders and EP 3139917: Cobalt protoporphyrin IX for the treatment of blood-related disorders granted to the Jagiellonian University. MM declares no conflict of interest.